ZA754051B - Improvements relating to immunological preparations - Google Patents

Improvements relating to immunological preparations

Info

Publication number
ZA754051B
ZA754051B ZA00754051A ZA754051A ZA754051B ZA 754051 B ZA754051 B ZA 754051B ZA 00754051 A ZA00754051 A ZA 00754051A ZA 754051 A ZA754051 A ZA 754051A ZA 754051 B ZA754051 B ZA 754051B
Authority
ZA
South Africa
Prior art keywords
improvements relating
immunological preparations
immunological
preparations
relating
Prior art date
Application number
ZA00754051A
Other languages
English (en)
Inventor
G Gregoriadis
A Allison
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of ZA754051B publication Critical patent/ZA754051B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
ZA00754051A 1974-06-25 1975-06-25 Improvements relating to immunological preparations ZA754051B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28131/74A GB1502774A (en) 1974-06-25 1974-06-25 Immunological preparations

Publications (1)

Publication Number Publication Date
ZA754051B true ZA754051B (en) 1976-07-28

Family

ID=10270755

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00754051A ZA754051B (en) 1974-06-25 1975-06-25 Improvements relating to immunological preparations

Country Status (9)

Country Link
US (1) US4053585A (fr)
JP (1) JPS5126218A (fr)
AU (1) AU507372B2 (fr)
BE (1) BE830629A (fr)
CA (1) CA1047921A (fr)
DE (1) DE2528411A1 (fr)
FR (1) FR2276062A1 (fr)
GB (1) GB1502774A (fr)
ZA (1) ZA754051B (fr)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5014264A (fr) * 1973-06-07 1975-02-14
US4117113A (en) * 1974-06-25 1978-09-26 National Research Development Corporation Immunological preparations
US4148876A (en) * 1975-09-29 1979-04-10 Burroughs Wellcome Co. Biological preparations
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
JPS53120247A (en) * 1977-03-30 1978-10-20 Toshiba Corp A/d converter
CH624011A5 (fr) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
US4377567A (en) 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
NL7900459A (nl) * 1979-01-19 1980-07-22 Hendrik Coenraad Hemker Prof D Farmaceutisch preparaat en werkwijze ter bereiding daarvan.
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4235877A (en) * 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4261975A (en) * 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
JPS5719662A (en) * 1980-07-09 1982-02-01 Fuji Photo Film Co Ltd Preparation of microcapsule reagent for immune reaction
EP0088046B1 (fr) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipides en phase aqueuse
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
JPS60153640A (ja) * 1984-01-23 1985-08-13 Santetsuku Kk 積分型ａｄ変換器
JPS60155119A (ja) * 1984-01-24 1985-08-15 Toubishi Yakuhin Kogyo Kk 抗体産生誘起物質
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US5897873A (en) * 1984-04-12 1999-04-27 The Liposome Company, Inc. Affinity associated vaccine
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
JPS61117925A (ja) * 1984-11-13 1986-06-05 Yokogawa Electric Corp アナログ・デイジタル変換器
US5622713A (en) * 1985-09-17 1997-04-22 The Regents Of The University Of California Method of detoxifying animal suffering from overdose
ES2039229T3 (es) * 1986-01-14 1993-09-16 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
US4971801A (en) * 1986-06-09 1990-11-20 Cell Technology, Inc. Biologic response modifier
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
CA1323306C (fr) * 1987-03-05 1993-10-19 Mircea C. Popescu Preparation comprenant une solution lipidique et un agent pharmacologique
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5026557A (en) * 1987-09-09 1991-06-25 The Liposome Company, Inc. Adjuvant composition
JP2560747B2 (ja) * 1987-09-22 1996-12-04 ミノルタ株式会社 光電変換装置
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
WO1990001947A1 (fr) * 1988-08-25 1990-03-08 The Liposome Company, Inc. Vaccin a affinite associee
JPH04500203A (ja) * 1988-08-25 1992-01-16 ザ　リポソーム　カンパニー，インコーポレイテッド インフルエンザワクチンおよび新規なアジュバント
FR2650181B1 (fr) * 1989-07-27 1993-12-03 Laboratoire Stallergenes Procede pour combiner un melange de substances heterogenes a des liposomes
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
NL9000207A (fr) * 1990-01-29 1991-08-16 Duphar Int Res
DE4007315A1 (de) * 1990-03-08 1991-09-12 Behringwerke Ag Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5246707A (en) * 1990-04-26 1993-09-21 Haynes Duncan H Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
WO1992004887A1 (fr) * 1990-09-25 1992-04-02 Kyowa Hakko Kogyo Co., Ltd. Production de lymphocites t cytotoxiques
WO1992008448A1 (fr) * 1990-11-09 1992-05-29 Cell Technology, Inc. Procede de prevention de myelosuppression due a la radiation ou aux medicaments
US5879685A (en) * 1991-05-08 1999-03-09 Schweiz, Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US6197311B1 (en) * 1991-07-25 2001-03-06 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
EP0596032B2 (fr) * 1991-07-25 2004-04-07 Idec Pharmaceuticals Corporation Induction de reponses de lymphocytes t cytotoxiques
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
DE4136553A1 (de) * 1991-11-06 1993-05-13 Biotechnolog Forschung Gmbh Impfstoff gegen schleimhauterreger und herstellungsverfahren
US5736141A (en) * 1992-06-05 1998-04-07 Dalhousie University Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
USRE37224E1 (en) * 1992-06-05 2001-06-12 Dalhousie University Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
CA2152765A1 (fr) 1994-06-30 1995-12-31 Jeroen Elisabeth-Joseph Knops Methodes pour traiter un trouble physiologique associe a un peptide amyloide beta
US6156319A (en) 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
FR2726764B1 (fr) * 1994-11-14 1997-01-31 Pasteur Merieux Serums Vacc Adjuvant pour composition vaccinale
US20040208922A1 (en) * 1995-06-07 2004-10-21 The Regents Of The University Of California Method for loading lipid like vesicles with drugs or other chemicals
US6576264B1 (en) 1995-10-17 2003-06-10 Skyepharma Canada Inc. Insoluble drug delivery
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US5827532A (en) * 1997-01-31 1998-10-27 The Reagents Of The University Of California Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
ES2201673T3 (es) * 1998-02-11 2004-03-16 Rtp Pharma Corporation Combinacion de esteroides y acidos grasos poiinsaturados para el tratamiento de estados inflamatorios.
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
EP1079808B1 (fr) 1998-05-29 2004-02-11 Skyepharma Canada Inc. Compositions de microparticules a protection thermique et procede de sterilisation a la vapeur apres conditionnement
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
NZ511792A (en) 1998-11-20 2003-08-29 Skyepharma Canada Inc Dispersible phospholipid stabilized microparticles
AU5711501A (en) 2000-04-20 2001-11-07 Rtp Pharma Inc Improved water-insoluble drug particle process
US6634576B2 (en) 2000-08-31 2003-10-21 Rtp Pharma Inc. Milled particles
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
FR2814958B1 (fr) * 2000-10-06 2003-03-07 Aventis Pasteur Composition vaccinale
ATE357216T1 (de) * 2001-02-22 2007-04-15 Jagotec Ag Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
US20030007973A1 (en) * 2001-06-22 2003-01-09 Lynes Michael A. Methods and compositions for manipulation of the immune response using anti-metallothionein antibody
WO2005013918A2 (fr) 2003-02-28 2005-02-17 The Trustees Of The University Of Pennsylvania Compositions, methodes et kits de vaccins a base de sous-unite de poxvirus
JP5114628B2 (ja) * 2005-02-25 2013-01-09 国立大学法人三重大学 リポソームワクチンの作製法
US8956646B2 (en) 2010-08-14 2015-02-17 The Regents Of The University Of California Zwitterionic lipids
ES2959258T3 (es) 2013-02-07 2024-02-22 Childrens Medical Center Antígenos proteicos que proporcionan protección contra la colonización y/o la enfermedad neumocócicas

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1015251A (en) * 1963-03-12 1965-12-31 Glaxo Lab Ltd Aqueous pharmaceutical compositions in capsule form
US3317393A (en) * 1964-06-08 1967-05-02 Robert M Chanock Immunization by selective infection of the intestinal tract with an encapsulated live virus
GB1143545A (en) * 1965-03-25 1969-02-26 Wellcome Found Injectable vaccine emulsions
US3492399A (en) * 1965-09-27 1970-01-27 Samuel J Prigal Emulsion compositions and methods
GB1171125A (en) * 1966-06-08 1969-11-19 Glaxo Lab Ltd Improvements in or relating to Injectable Preparations
FR7461M (fr) * 1968-06-19 1970-01-05
US3594476A (en) * 1969-05-12 1971-07-20 Massachusetts Inst Technology Submicron aqueous aerosols containing lecithin
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
NL7012832A (fr) * 1970-08-29 1972-03-02
US3715432A (en) * 1971-01-22 1973-02-06 Massachusetts Inst Technology Submicron aqueous aerosols containing lecithin
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
DE2221122C3 (de) * 1972-04-28 1979-03-01 Steigerwald Strahltechnik Gmbh, 8000 Muenchen Anastigmatisches magnetisches Elektronenstrahl-Ablenksystem, Verfahren zu seinem Betrieb und Anwendung
US3887698A (en) * 1973-03-12 1975-06-03 Univ Leland Stanford Junior Sacs with epitopic sites on walls enclosing stable free radicals

Also Published As

Publication number Publication date
FR2276062A1 (fr) 1976-01-23
DE2528411C2 (fr) 1987-08-20
AU507372B2 (en) 1980-02-14
FR2276062B1 (fr) 1978-11-17
US4053585A (en) 1977-10-11
GB1502774A (en) 1978-03-01
AU8243875A (en) 1977-01-06
BE830629A (fr) 1975-10-16
DE2528411A1 (de) 1976-02-05
JPS6238330B2 (fr) 1987-08-17
CA1047921A (fr) 1979-02-06
JPS5126218A (en) 1976-03-04

Similar Documents

Publication Publication Date Title
ZA754051B (en) Improvements relating to immunological preparations
PH11632A (en) Hair preparation
HK25780A (en) Improvements relating to containers
ZA74741B (en) Improvements relating to refrigerators
ZA753272B (en) Improvements relating to pyridobenzodiazepinones
ZA752639B (en) Preparation of alpha-6-deoxy-5-hydroxy-tetracycline
JPS5138737A (en) Tairubarishikohoho to tairubaryo yunitsuto
JPS5126235A (en) Budooto to katooganjusuru ekiseigongobutsu no shorihoho
JPS5129327A (en) Nashijishori to dojiniarumaitoshorisuru hoho
JPS51125712A (en) Preparation of vincamin 22ketoglutarate
ZA75174B (en) Improvements relating to framework structure
JPS519018A (en) Nitsukeru to kobaruto no bunri hoho
IL48695A (en) Preparation of -oxo-thiodimethylamides
ZA755457B (en) Improvements relating to tents
AU7835075A (en) Preparation of cis-vincamine
JPS51125221A (en) Preparation of ethynylbenzenes
JPS5130344A (en) Teidenatsusochi to sonoseizohoho
JPS5175201A (en) Uzumakihonpu to sonoseiho
JPS5171376A (en) Goseijushiseibendo no seizohoho to sonosochi
ZA757902B (en) Preparation of -6-deoxytetracyclines
JPS5132913A (en) Nisoinbaatasochi to nisojudodendokitokaranarukahensokusochi
JPS5155590A (en) Oshifune to baajinorenketsusochi
JPS5174924A (en) Kogensuitokusei to kojinseiojusuru taabinyokunadonoseizohoho
AU490440B2 (en) Improvements relating to conveyors
HK27878A (en) Preparation of 2-aminomethyl-pyrrolidine